Literature DB >> 7488163

Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1.

G L Wang1, B H Jiang, G L Semenza.   

Abstract

Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric bHLH-PAS protein essential for erythropoietin gene transcription in hypoxic cells. Here we show that both 2-aminopurine and sodium fluoride, inhibitors of serine/threonine kinases and phosphatases, respectively, interfered with the hypoxic induction of HIF-1 DNA-binding activity and expression of HIF-1 alpha and HIF-1 beta(ARNT) subunits. Genistein, an inhibitor of tyrosine kinases, completely blocked the synthesis of both HIF-1 subunits as well as HIF-1 DNA-binding activity. Sodium orthovanadate, an inhibitor of tyrosine phosphatases increased the basal level of HIF-1 proteins and HIF-1 activity. These data suggest that protein phosphorylation events play an important role in the hypoxia signal-transduction pathway that leads to synthesis of HIF-1 alpha and HIF-1 beta proteins and the induction of HIF-1 DNA-binding activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488163     DOI: 10.1006/bbrc.1995.2674

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  41 in total

1.  Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element.

Authors:  A Minchenko; J Caro
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

Review 2.  High altitude hypoxia: an intricate interplay of oxygen responsive macroevents and micromolecules.

Authors:  S Sarkar; P K Banerjee; W Selvamurthy
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

3.  Cardiac myocyte p38α kinase regulates angiogenesis via myocyte-endothelial cell cross-talk during stress-induced remodeling in the heart.

Authors:  Beth A Rose; Tomohiro Yokota; Vishnu Chintalgattu; Shuxun Ren; Luisa Iruela-Arispe; Aarif Y Khakoo; Susumu Minamisawa; Yibin Wang
Journal:  J Biol Chem       Date:  2017-06-21       Impact factor: 5.157

4.  Molecular Validation of Chondrogenic Differentiation and Hypoxia Responsiveness of Platelet-Lysate Expanded Adipose Tissue-Derived Human Mesenchymal Stromal Cells.

Authors:  Catalina Galeano-Garces; Emily T Camilleri; Scott M Riester; Amel Dudakovic; Dirk R Larson; Wenchun Qu; Jay Smith; Allan B Dietz; Hee-Jeong Im; Aaron J Krych; A Noelle Larson; Marcel Karperien; Andre J van Wijnen
Journal:  Cartilage       Date:  2016-07-21       Impact factor: 4.634

Review 5.  Modulation of hypoxia-inducible factors (HIF) from an integrative pharmacological perspective.

Authors:  Francisco Javier Rodríguez-Jiménez; Victoria Moreno-Manzano
Journal:  Cell Mol Life Sci       Date:  2011-10-08       Impact factor: 9.261

Review 6.  Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system.

Authors:  Jaewon Lee; Dong-Gyu Jo; Daeui Park; Hae Young Chung; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

7.  Hypoxia-inducible factor-1 and activator protein-1 modulate the upregulation of CYP3A6 induced by hypoxia.

Authors:  Caroline Fradette; Patrick du Souich
Journal:  Br J Pharmacol       Date:  2003-10-14       Impact factor: 8.739

Review 8.  NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology.

Authors:  Randall S Frey; Masuko Ushio-Fukai; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

Review 9.  Prodeath or prosurvival: two facets of hypoxia inducible factor-1 in perinatal brain injury.

Authors:  Wanqiu Chen; Robert P Ostrowski; Andre Obenaus; John H Zhang
Journal:  Exp Neurol       Date:  2008-11-11       Impact factor: 5.330

Review 10.  Development of HIF-1 inhibitors for cancer therapy.

Authors:  Barbara Onnis; Annamaria Rapisarda; Giovanni Melillo
Journal:  J Cell Mol Med       Date:  2009-08-08       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.